Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 13:2022:5262963.
doi: 10.1155/2022/5262963. eCollection 2022.

HIF-3 α-Induced miR-630 Expression Promotes Cancer Hallmarks in Cervical Cancer Cells by Forming a Positive Feedback Loop

Affiliations

HIF-3 α-Induced miR-630 Expression Promotes Cancer Hallmarks in Cervical Cancer Cells by Forming a Positive Feedback Loop

Qiaohui Gao et al. J Immunol Res. .

Abstract

Purpose: Hypoxia has crucial functions in the development and metastasis of cervical cancer by inducing the expression of numerous genes, including microRNA genes. But we know little about how the hypoxia factors and microRNAs orchestrate to regulate hallmarks of cervical cancer cells.

Methods: We conducted RNA sequencing (RNA-seq) and chromatin immunoprecipitation sequencing (ChIP-seq) experiments to investigate the targets of HIF-3α or miR-630. ChIP-qPCR and RT-qPCR were carried out to validate the results of ChIP-seq and RNA-seq. Cellular, molecular, and radiation experiments were conducted to explore the functions of miR-630.

Results: In this study, we showed that hypoxia-induced overexpression of HIF-3α increased the expression of dozens of miRNAs, including miR-630. Hypoxia could also directly induce miR-630 expression. ChIP-seq data showed that HIF-3α activates miR-630 expression by directly binding to the promoter of its host gene. Meanwhile, stable overexpression of miR-630 increased the expression of HIF-3α, but repressed the expression of HIF-1α, indicating a positive feedback loop between HIF-3α and miR-630. Consequently, stable overexpression of miR-630 in HeLa cells promotes cancer hallmarks, including radioresistance, inhibition of apoptosis, increased migration and invasion, and EMT-mediated metastasis. Meanwhile, inhibition of miR-630 showed opposite features.

Conclusion: Taken together, our findings indicate a novel hypoxia-induced HIF-3α and miR-630 regulatory feedback loop contributing to metastasis and progression of cervical cancer cells and suggest that HIF-3α and miR-630 might act as potential biomarkers and therapeutic targets for cervical cancer in the future.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
HIF-1α and HIF-3α promote miR-630 expression under hypoxia. (a) Bar plot showed the increased RNA level of HIF1A and HIF3A under hypoxia by RT-qPCR experiment. (b) Western blot result showed the increased protein level of HIF1A and HIF3A under hypoxia. (c) Bar plot showed the DEmiR number in HIF-1α vs. in the vacant group and in HIF-3α vs. in the vacant group. (d) Hierarchical clustering heat map showed the elevated expression level of selected miRNAs in HIF-1α and HIF-3α OE samples. (e) Bar plot showed the increased expression level of miR-630 under hypoxia by RT-qPCR experiment. (f) Bar plot showed the expression level of miR-630 under hypoxia by RT-qPCR experiment.
Figure 2
Figure 2
HIF-3α overexpression globally regulates gene expression in HeLa cells. (a) Sample correlation results showed a clear separation between HIF-3α OE and vacant samples. (b) Volcano plot showed the DEG results of HIF-3α OE and vacant samples. (c) Hierarchical clustering heat map showed the dominant upregulated genes after HIF-3α OE. (d) Top functionally enriched GO BP terms and KEGG pathways for HIF-3α upregulated genes. (e) Heat map showed the upregulated genes by HIF-3α OE. (f) Bar plot showed the expression levels of HIF1A transcripts upon HIF3A overexpression and repression.
Figure 3
Figure 3
ChIP-seq results of HIF-3α showed its binding preference at promoter region. (a) Read density heat map plot showed the enriched read distribution around gene TSS sites. (b) Pie chart showed the percentage of peaks from four genomic regions. (c) Bar plot showed the percentage of bound genes classified by their coding types. The white and brown bars represent two biological replicates of HIF-3α ChIP-seq data. (d) Venn diagram showed HIF-3α-bound genes and HIF-3α-regulated DEGs. (e) Read distribution of bound miRNA miR-137. Red rectangle represents the bound region of HIF-3α. (f) Bar plot showed the validation results of ChIP-qPCR experiments.
Figure 4
Figure 4
RNA-seq revealed the functions of miR-630 targets in HeLa cells. (a) Read distribution plot showed the significant HIF3A binding density in the promoter region of miR-630 host gene. Red frame represented the HIF3A binding peak. (b) Bar plot showed the ChIP-qPCR results of the HIF-3a binding density in the promoter region of miR-630 host gene. (c) Western blot showed the expression changes of HIF1A and HIF3A upon miR-630 overexpression and knockdown. (d) Bar plot showed the quantified levels of WB results shown in (c). Three biological replicates were included in this panel. (e) Bar plot showed the enriched GO BP terms for upregulated genes (left) and downregulated genes (right) by miR-630 inhibition. (f) Bar plot showed the increased expression levels of ATM and ATR by miR-630 inhibition. (g) Bar plot showed the increased expression level of HIF1A and the decreased expression level of HIF3A by miR-630 inhibition.
Figure 5
Figure 5
miR-630 increases the radioresistance and significantly reduces the apoptosis level of HeLa cells under spontaneous and radiation-treated conditions. (a) RT-qPCR analysis of lentiviral overexpression and inhibition of miR-630 in HeLa cell lines. (b) Colony formation assay showing the higher radioresistance by miR-630 overexpression and opposite phenotype by miR-630 inhibition. p < 0.05. (c, d) Overexpression of miR-630 increased the cell proliferation rates of HeLa cells under irradiation conditions. (e) miR-630 overexpression reduced the spontaneous apoptosis levels of HeLa cells. (f, g) miR-630 overexpression reduced the radiation-induced apoptosis levels of HeLa cells. (h) Western blotting showing the expression changes of several apoptosis markers in HeLa cells with miR-630 overexpression or inhibition under radiation-treated conditions. (i) Western blotting showing the expression changes of several apoptosis markers in HeLa cells with miR-630 overexpression or inhibition under spontaneous conditions.
Figure 6
Figure 6
Effects of miR-630 on migration and invasion of HeLa cell line and miR-630 promoted HeLa metastasis is mediated by the EMT. (a) Wound-healing assay was performed to compare the migratory capabilities of HeLa, HeLa-virus control, and HeLa-miR-630-inhibitor cells. p < 0.05. The graph shows the quantification of migration rates analyzed in HeLa, HeLa-virus control, HeLa-miR-630, and HeLa-miR-630-inhibitor cells, respectively. (b, c) Representative invasion images of HeLa, HeLa-virus control, HeLa-miR-630, and HeLa-miR-630-inhibitor cells by transwell invasion assay. The right graph shows the quantification of invasion numbers analyzed in four cells. (d) Heat map plot showed the expression level changes of miR-630 targets that are transcription factors related to EMT. (e) Bar plot showed the RT-qPCR results of transcription factor EP300 upon miR-630 overexpression and knockdown. (f) The morphology of HeLa, HeLa-virus control, HeLa-miR-630, and HeLa-miR-630-inhibitor cells. Note: (A) cell space became wide; (B) spindle-cell morphology formed; (C) pseudopodia were stretched out. Scale bar = 100. (g) WB was performed to analyze the expression of EMT makers. (h) Cellular staining showed the cytokeratin distribution in the HeLa cells. (i) Working model showed the HIF3A-miR-630 regulatory loop in HeLa cells.

Similar articles

Cited by

References

    1. Sung H., Ferlay J., Siegel R. L., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians . 2021;71(3):209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Global Burden of Disease Cancer Collaboration, Fitzmaurice C., Dicker D., et al. The global burden of cancer 2013. JAMA Oncology . 2015;1(4):505–527. doi: 10.1001/jamaoncol.2015.0735. - DOI - PMC - PubMed
    1. Cohen P. A., Jhingran A., Oaknin A., Denny L. Cervical cancer. The Lancet . 2019;393(10167):169–182. - PubMed
    1. Huang Z., Mayr N. A., Yuh W. T., et al. Predicting outcomes in cervical cancer: a kinetic model of tumor regression during radiation therapy. Cancer Research . 2010;70(2):463–470. doi: 10.1158/0008-5472.CAN-09-2501. - DOI - PMC - PubMed
    1. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Seminars in Radiation Oncology . 2004;14(3):198–206. doi: 10.1016/j.semradonc.2004.04.008. - DOI - PubMed